Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease. [electronic resource]
- Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Mar 2016
- 41-5 p. digital
Publication Type: Clinical Trial; Journal Article
1532-2653
10.1016/j.jocn.2015.05.059 doi
Adult Aged Antiparkinson Agents--administration & dosage Australia Carbidopa--administration & dosage Dopamine Agents--administration & dosage Duodenum Dyskinesias--prevention & control Female Gels Humans Levodopa--administration & dosage Male Middle Aged Parkinson Disease--drug therapy Peripheral Nervous System Diseases--chemically induced Prospective Studies Psychomotor Performance--drug effects Quality of Life